Bliss GVS Pharma Limited BLISSGVS.NS Stock
Bliss GVS Pharma Limited Price Chart
Bliss GVS Pharma Limited BLISSGVS.NS Financial and Trading Overview
Bliss GVS Pharma Limited stock price | 103.5 INR |
Previous Close | 81.1 INR |
Open | 82.35 INR |
Bid | 82.2 INR x 0 |
Ask | 82.3 INR x 0 |
Day's Range | 81.65 - 83.15 INR |
52 Week Range | 69.2 - 91.3 INR |
Volume | 212.5K INR |
Avg. Volume | 168.03K INR |
Market Cap | 8.55B INR |
Beta (5Y Monthly) | 0.488698 |
PE Ratio (TTM) | 12.630769 |
EPS (TTM) | 7.11 INR |
Forward Dividend & Yield | 0.5 (0.63%) |
Ex-Dividend Date | July 12, 2023 |
1y Target Est | N/A |
BLISSGVS.NS Valuation Measures
Enterprise Value | 8.13B INR |
Trailing P/E | 12.630769 |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 1.1382006 |
Price/Book (mrq) | 0.91349095 |
Enterprise Value/Revenue | 1.081 |
Enterprise Value/EBITDA | 6.928 |
Trading Information
Bliss GVS Pharma Limited Stock Price History
Beta (5Y Monthly) | 0.488698 |
52-Week Change | 9.66% |
S&P500 52-Week Change | 20.43% |
52 Week High | 91.3 INR |
52 Week Low | 69.2 INR |
50-Day Moving Average | 75.32 INR |
200-Day Moving Average | 75.24 INR |
BLISSGVS.NS Share Statistics
Avg. Volume (3 month) | 168.03K INR |
Avg. Daily Volume (10-Days) | 205.28K INR |
Shares Outstanding | 104.2M |
Float | 34.75M |
Short Ratio | N/A |
% Held by Insiders | 65.41% |
% Held by Institutions | 9.20% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0.5 |
Trailing Annual Dividend Yield | 0.61% |
5 Year Average Dividend Yield | 62.00% |
Payout Ratio | 0.0744 |
Last Split Factor | 8:5 |
Financial Highlights
Fiscal Year
Fiscal Year Ends | March 31, 2023 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | March 31, 2024 |
Profitability
Profit Margin | 9.42% |
Operating Margin (ttm) | 13.12% |
Gross Margin | 46.60% |
EBITDA Margin | 15.60% |
Management Effectiveness
Return on Assets (ttm) | 5.44% |
Return on Equity (ttm) | 8.70% |
Income Statement
Revenue (ttm) | 7.52B INR |
Revenue Per Share (ttm) | 72.45 INR |
Quarterly Revenue Growth (yoy) | 10.59% |
Gross Profit (ttm) | N/A |
EBITDA | 1.17B INR |
Net Income Avi to Common (ttm) | 708.59M INR |
Diluted EPS (ttm) | 6.5 |
Quarterly Earnings Growth (yoy) | -83.00000000000000000000000000000000% |
Balance Sheet
Total Cash (mrq) | 1.08B INR |
Total Cash Per Share (mrq) | 10.98 INR |
Total Debt (mrq) | 1.02B INR |
Total Debt/Equity (mrq) | 11.11 INR |
Current Ratio (mrq) | 3.608 |
Book Value Per Share (mrq) | 89.875 |
Cash Flow Statement
Operating Cash Flow (ttm) | 343.14M INR |
Levered Free Cash Flow (ttm) | 199.88M INR |
Profile of Bliss GVS Pharma Limited
Country | India |
State | N/A |
City | Mumbai |
Address | 102, Hyde Park |
ZIP | 400072 |
Phone | 91 22 4216 0000 |
Website | https://www.blissgvs.com |
Industry | Drug Manufacturers-Specialty & Generic |
Sector(s) | Healthcare |
Full Time Employees | N/A |
Bliss GVS Pharma Limited develops, manufactures, and markets pharmaceutical formulations in India. It offers pharma products, including capsules, creams/gels/ointments, dry powder for injections and oral suspensions, effervescent tablets, eye/ear drops, injections, liquid preparations, lotions, lozenges, nasal solutions, oral solids, parenterals, pessaries, sachets, soft gelatin capsules, suppositories, suspensions, syrups, tablets, topical preparations, and transdermal patches. The company also provides other healthcare products, such as balms, creams, lotions, lozenges, nasal inhalers, over the counter products, petroleum jellies, powders, roll-ons, shampoos, soaps, solutions, sprays, syrups, and vaginal washes. In addition, it offers therapeutic products consisting of anti-bacterial, anti-dandruff shampoo, amino acid preparation, iron tonic, antitussive, appetite stimulant, anti-allergic, body supplement, anti-biotic, anti-diabetic, anti-diarrheal, anti-emetic, anti-fungal, anti-haemorrhoidal, anti-helmintic, anti-infective, anti-inflammatory, anti-malarial, anti-microbial, anti-migraine, anti-oxidant, anti-protozoal, ear wax solvent, anti-pyretic, anti-septic, anti-spasmodic, anti-ulcer, and anti-ulcerant; and analgesic, oral rehydration, antacid, anxiolytic, appetizer, cough syrup, erectile dysfunction, haematinic, hand sanitizer, health supplement, insecticide, laryngitis, pharyngitis, laxative, lubricant, mosquito repellant, nasal decongestant, nutritional supplement, moisturizer, prickly heat powder, skin lightening lotion, vaginal contraceptive, vaginal hygiene, and vitamin supplements, as well as medicated, complexion, moisturizing, and total protection soaps. The company also exports its products. Bliss GVS Pharma Limited was incorporated in 1984 and is based in Mumbai, India.
Q&A For Bliss GVS Pharma Limited Stock
What is a current BLISSGVS.NS stock price?
Bliss GVS Pharma Limited BLISSGVS.NS stock price today per share is 103.5 INR.
How to purchase Bliss GVS Pharma Limited stock?
You can buy BLISSGVS.NS shares on the NSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Bliss GVS Pharma Limited?
The stock symbol or ticker of Bliss GVS Pharma Limited is BLISSGVS.NS.
Which industry does the Bliss GVS Pharma Limited company belong to?
The Bliss GVS Pharma Limited industry is Drug Manufacturers-Specialty & Generic.
How many shares does Bliss GVS Pharma Limited have in circulation?
The max supply of Bliss GVS Pharma Limited shares is 104.74M.
What is Bliss GVS Pharma Limited Price to Earnings Ratio (PE Ratio)?
Bliss GVS Pharma Limited PE Ratio is 14.55696200 now.
What was Bliss GVS Pharma Limited earnings per share over the trailing 12 months (TTM)?
Bliss GVS Pharma Limited EPS is 7.11 INR over the trailing 12 months.
Which sector does the Bliss GVS Pharma Limited company belong to?
The Bliss GVS Pharma Limited sector is Healthcare.